Role of cellular proliferation and apoptosis in the growth of xanthogranulomas

American Journal of Dermatopathology

Volumn 20, Issue 1, 1998, Pages 17-21

  Mancini, Anthony J ^a,d   Prieto, Victor G ^c   Smoller, Bruce R ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Apoptosis; Histiocytes; Xanthogranuloma

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HISTIOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; ONSET AGE; PRIORITY JOURNAL; XANTHOGRANULOMA;

ADULT; AGE FACTORS; APOPTOSIS; CELL DIVISION; CHILD; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KI-67 ANTIGEN; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; XANTHOGRANULOMA, JUVENILE;

EID: 0031889191     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199802000-00004     Document Type: Article

References (21)

1. Adamson HG. Society intelligence: the dermatologic society of London. Br J Dermatol 1905;17:222.
2. Helwig EB, Hackney VC. Juvenile xanthogranuloma (nevoxanthoendothelioma). Am J Pathol 1954;30:625-6.
3. Tahan SR, Pastel-Levy C, Bhan AK, Mihm Jr. MC. Juvenile xanthogranuloma, clinical and pathologic characterization. Arch Pathol Lab Med 1989;113:1057-61.
4. Gianotti F. Cutaneous proliferative histiocytoses in children. Giornale Italiano di Dermatolgia e Venereologia 1980;115:59-66.
5. Gianotti F, Caputo R. Histiocytic syndromes: a review. J Am Acad Dematol 1985;13:383-404.
6. Tanz WS, Schwanz RA, Janniger CK. Juvenile xanthogranuloma. Cutis 1994;54:241-5.
7. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990;17:489-503.
8. Hitchcock CL. Ki-67 as a means to simplify analysis of tumor cell proliferation [Editorial], Am J Clin Pathol 1991;96:444-6.
9. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
10. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB-1. Histopathoology 1993;22:355-60.
11. Vaux DL. Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 1993;90: 786-9.
12. Hockenberry DM, Zutter M, Hickey W et al. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-5.
13. Williams GT. Programmed cell death: apoptosis and oncogenesis. Cell 1991;65:1097-8.
14. LeBrun DP, Warnke RA, Cleary ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1003;142:743-53.
15. Smoller BR, Van de Rijn M, LeBrun D, Warnke RA. Bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas. Br J Dermatol 1994;131:28-31.
16. Bindl JM, Warnke RA. Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. Am J Clin Pathol 1986;490-3.
17. Botella-Estrada R, Sanmartin O, Grau M, Alegre V, Mas C, Aliaga A. Juvenile xanthogranuloma with central nervous system involvement. Pear Dermatol 1993;10:64-8.
18. Lever WF, Schaumburg-Lever G. Histopathology of the skin. 7th ed. Philadelphia: JB Lippincott Company, 1990:442-3.
19. Zelger B, Cerio R, Orchard G, Wilson-Jones E. Juvenile and adult xanthogranuloma. A histological and immunological comparison. Am J Surg Pathol 1994;18:126-35.
20. Misery L, Boucheron S, Claudy AL. Factor XIIIa expression in juvenile xanthogranuloma. Acta Derm Venereol (Stockh) 1994;74:43-4.
21. Marrogi A, Dehner LP, Coffin CM, Wick MR. Benign cutaneous histiocytic tumors in childhood and adolescence, excluding Langerhans' cell proliferations. Am J Dermatopathol 1992;14:8-18.